Sexually Transmitted Diseases, HIV Infection and AIDS

         The Regional Committee,

         Having considered the annual report on sexually transmitted diseases (STDs), HIV infection and AIDS;*

         Noting the expected increase in HIV infections and AIDS cases in the next few years in the Region, and the potential impact on the people and on health systems;

         Noting also the high incidence of STDs in most Member States of the Region and the scientific evidence that STD prevention and control can reduce HIV incidence, in particular among commercial sex workers and their clients;

         Acknowledging that the estimates and projections prepared by the Regional Office have proved broadly accurate, but that the increasing use of antireretroviral therapies might change future estimates in those countries where such therapies are accessible;

         Further acknowledging that such treatment will have a role in treatment of AIDS patients; in post-exposure prophylaxis; and in reduction of mother-to-child transmission, but that their role will be limited by current costs and the problems associated with current regimens;

  1. URGES Member States:
    (1) to strengthen commitment for the support of STD prevention and control programmes;
    (2) to mobilize additional resources for these programmes;
    (3) to strengthen the epidemiological surveillance of STDs, HIV infection, AIDS and related bloodborne infections;
    (4) to further strengthen health promotion campaigns and STD and HIV prevention and control programmes, particularly those targeting commercial sex workers, their clients, injecting drug users and youth;
  2. REQUESTS the Regional Director:
    (1) to further strengthen technical collaboration with Member States, in particular those facing rapidly increasing numbers of infections, in the prevention and control of STDs and HIV/AIDS and to strengthen the technical capability within WHO;
    (2) to continue to improve the regional surveillance system for STDs, HIV, AIDS and related bloodborne infections;
    (3) to intensify WHO participation in UNAIDS theme group activities at country level, and coordination and implementation of UNAIDS activities at regional and national levels;
    (4) to continue to identify and mobilize resources for STD and HIV/AIDS activities;
    (5) to continue to refine the methodology for estimates and projections;
    (6) to monitor research on antiretroviral agents, including research on how costs of such agents may be reduced, and to report to the Regional Committee on significant developments;
    (7) to continue to report annually to the Regional Committee on the situation of STDs and HIV/AIDS in the Region, and on developments relating to UNAIDS.

* WPR/RC49/6

16 September 1998

Print      Bookmark   Feedback   More